Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niko Thio

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.
Cell Reports|August 17, 2022
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cellsEmily Gruber, Joan So, Alexander C Lewis, et al.
European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.
Journal for Immunotherapy of Cancer|January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primaryAtara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
Nature Communications|June 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanomaAndrea Di Pietro, Lewis Au, Patrick Crock, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
The Journal of Pathology|October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primaryAtara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 3, 2020
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumorsChristopher R McEvoy, Holly Holliday, Niko Thio, et al.
Cell Reports|August 17, 2022
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cellsEmily Gruber, Joan So, Alexander C Lewis, et al.
European Urology|April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 TrialsAlexander D Sherry, Van To, Criselle D'souza, et al.
Journal for Immunotherapy of Cancer|January 31, 2023
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primaryAtara Posner, Tharani Sivakumaran, Andrew Pattison, et al.
Nature Communications|June 11, 2026
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanomaAndrea Di Pietro, Lewis Au, Patrick Crock, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
The Journal of Pathology|October 26, 2022
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primaryAtara Posner, Owen Wj Prall, Tharani Sivakumaran, et al.
NPJ Breast Cancer|May 13, 2021
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjectsNa Li, Magnus Zethoven, Simone McInerny, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Nature Communications|September 4, 2019
The molecular origin and taxonomy of mucinous ovarian carcinomaDane Cheasley, Matthew J Wakefield, Georgina L Ryland, et al.
Pageof 2